Controlling Toxicity of Aminoquinoline Compounds
AssigneeThe University of Mississippi
InventorsLarry Walker, Babu Tekwani, Lalit Tripathi
Life of this patent
Estimating the term…
Abstract
A method of controlling toxicity to a user caused by administration to the user of an aminoquinoline compound comprising administering to the user a toxicity controlling amount of at least one inhibitor of a cytochrome P450 (CYP) enzyme.
Claims17
A method of controlling toxicity to a user caused by administration to the user of an aminoquinoline compound comprising administering to the user a toxicity controlling amount of at least one inhibitor of a cytochrome P450 (CYP) enzyme.
A composition comprising at least one aminoquinoline and at least one cytochrome P450 (CYP) enzyme inhibitor and acceptable carriers or excipients.
A two package composition which is adapted for administration together comprising a first composition comprising at least one 8-aminoquinoline and an acceptable carrier or excipient and a second composition comprising at least one cytochrome P450 (CYP) enzyme inhibitor and an acceptable carrier or excipient.
Dependencies are inferred from the claim text.